SIMON S. LEOPOLD, M.D., F.A.C.P.; LOUIS M. LIEBERMAN, M.D.
Therapeutic innovations begin with an original idea or more often with a new application of an old one and, if promising and spectacular, may be followed by premature and unjustified optimism. After experimentation and thorough clinical trial have established their status, they are either accepted or rejected.
In connection with the therapeutic use of pneumothorax in pneumonia we have passed through a period of enthusiasm which was initiated primarily by empirical use of the method; and only later obtained the confirmation of experimental evidence. That this order was the reverse of what it should have been is beside the point.
Learn more about subscription options.
Register Now for a free account.
LEOPOLD SS, LIEBERMAN LM. THE PRESENT STATUS OF ARTIFICIAL PNEUMOTHORAX IN THE TREATMENT OF LOBAR PNEUMONIA(THE PRESENT STATUS OF ARTIFICIAL PNEUMOTHORAX IN THE TREATMENT OF LOBAR PNEUMONIA*). Ann Intern Med. 1935;9:19–25. doi: 10.7326/0003-4819-9-1-19
Download citation file:
Published: Ann Intern Med. 1935;9(1):19-25.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only